Research News and Research

RSS

Study evaluates hepatocyte transplantation as an alternative to liver transplantation

A research team from the National Taiwan University Hospital has evaluated the efficiency of transplanted hepatocyte (liver) cells in animal models severely damaged by two kinds of chemical toxicity to see whether and how transplanted hepatocytes were able to efficiently repopulate the toxin-induced, severely damaged livers.

2 Feb 2010

Studies suggest potential therapeutic targets for food poisoning, TB and autoimmune diseases

Researchers at National Jewish Health have discovered how the virulent food-borne bacteria Listeria monocytogenes induces infected immune cells to sabotage their own defensive response.

2 Feb 2010

CWRU receives $250,000 grant to advance interdisciplinary research and development in biomedicine

Case Western Reserve University (CWRU) said today that it received a $250,000 challenge grant from Johnson & Johnson Services, Inc. through The Johnson & Johnson Corporate Office of Science and Technology (COSAT), and its affiliates. The University will utilize this research grant to support science, medicine and engineering projects to improve human health.

2 Feb 2010

Findings could lead to new therapeutic strategies for obesity

Peptides that target blood vessels in fat and cause them to go into programmed cell death (termed apoptosis) could become a model for future weight-loss therapies, say University of Cincinnati (UC) researchers.

2 Feb 2010

Study shows antiviral drugs could offer protection against HIV, Ebola, herpes and hepatitis C

The development of antibiotics gave physicians seemingly miraculous weapons against infectious disease. Effective cures for terrible afflictions like pneumonia, syphilis and tuberculosis were suddenly at hand. Moreover, many of the drugs that made them possible were versatile enough to knock out a wide range of deadly bacterial threats.

2 Feb 2010

U.S. government resumes medical evacuations from Haiti; new food voucher distribution targeting women begins

"The U.S. government said on Sunday it would resume military evacuation flights" within 12 hours for critically ill and injured Haitians who were harmed in the Jan. 12 earthquake, Reuters reports (Rosenberg/Brown, 1/31). Medical evacuations had been suspended for a few days, but the reason for the suspension "is unclear as various government authorities have provided different explanations," the Wall Street Journal reports.

2 Feb 2010

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

A new therapeutic made from tobacco plants has been shown to arrest West Nile virus infection, according to a new study by Arizona State University scientist Qiang Chen and his colleagues.

2 Feb 2010

ADT can worsen heart risk factors and may increase the risk of heart attack

Androgen-deprivation therapy (ADT), commonly used to treat prostate cancer, can worsen heart risk factors and may increase the risk of heart attack and/or cardiac death, although the relationship between ADT and heart attack or cardiac death has not been definitively established, according to a science advisory published in Circulation: Journal of the American Heart Association and CA: A Cancer Journal for Clinicians.

2 Feb 2010

PET for children: CHOP-Penn researchers study reduction in radiation dosage

Studies have shown positron emission tomography's (PET) value as a minimally invasive, painless and safe diagnostic tool for many pediatric conditions. In a study published in the February issue of The Journal of Nuclear Medicine (JNM), researchers at the Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania (Penn) gathered data that may provide clinicians with new formulas-specific to pediatrics-to calculate the amount of radiotracer that should be injected based on the patient's weight.

2 Feb 2010

Smoking cessation increases cardiac health later in life

Smoking affects your cardiac health both before and after a major event like a heart attack. But how much? And does cutting back instead of quitting have a positive effect as well?

2 Feb 2010

SDI selected for third consecutive time as key monoclonal antibody provider

SDI (Strategic Diagnostics Inc.), a leading provider of biotechnology-based products and services for a broad range of life science, food safety, and industrial applications, today announced it has been selected again by Science Applications International Corporation - Frederick (SAIC-F) to develop monoclonal antibodies for the National Cancer Institute’s “Clinical Proteomic Technologies for Cancer” initiative (CPTC: http://proteomics.cancer.gov).

2 Feb 2010

Mich., R.I. look for cuts in Medicaid costs; Mass. Governor suggests taxes, fees to cover rising costs

The Holland (Mich.) Sentinel reports on possible Medicaid cuts in Michigan: "After an 8 percent reduction in Medicaid reimbursement for 2010, state health organizations say additional cuts for 2011 could be overwhelming.

2 Feb 2010

Scientists develop potential new treatment against ovarian cancer

Scientists at Georgia Tech and the Ovarian Cancer Institute have further developed a potential new treatment against cancer that uses magnetic nanoparticles to attach to cancer cells, removing them from the body.

2 Feb 2010

Mouse model demonstrates cell-to-cell connections between implanted stem cells and diseased cells

Investigators at Sanford-Burnham Medical Research Institute (Sanford-Burnham, formerly Burnham Institute for Medical Research), the Karolinska Institutet, Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School and Universit- Libre de Bruxelles have demonstrated in mouse models that transplanted stems cells, when in direct contact with diseased neurons, send signals through specialized channels that rescue the neurons from death.

2 Feb 2010

Decision Resources: Benlysta to garner more than $500M in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected regulatory approval in 2011 in the United States and Europe, Human Genome Sciences/GlaxoSmithKline's Benlysta will garner sales of more than $500 million in 2018 in the systemic lupus erythematosus drug market.

2 Feb 2010

Nursing jobs no longer recession-proof

"A few years ago, hospitals were offering nurses $10,000 signing bonuses, loan payoffs, even cars as incentives to battle a nursing shortage in Texas. Today, some nursing school graduates say they're fortunate to find a job," The Star-Telegram reports. "Three years ago there were three job offers for every graduate, said Dr. Pamela Frable, director of nursing at Texas Christian University's Harris College of Nursing and Health Sciences. But at graduation last summer, there were more students without a job than ever before.

2 Feb 2010

Some states mull requiring prescription for meth ingredients

"State and local efforts to thwart methamphetamine production by further limiting consumer access to a popular decongestant are pitting law enforcement against pharmacists and patients," USA Today reports.

2 Feb 2010

Companies may hit new anti-discrimination law when asking workers about health issues

Employers offering wellness and preventive health programs can sometimes run afoul of a new anti-discrimination law restricting their ability to ask workers about family medical histories, The Wall Street Journal reports.

2 Feb 2010

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

2 Feb 2010

FDA and PATH collaborate to advance pneumococcal vaccine development for children

The U.S. Food and Drug Administration (FDA) today announced a collaboration with PATH to advance development of a vaccine to protect children against diseases caused by Streptococcus pneumoniae (pneumococcus), especially pneumonia.

2 Feb 2010

Research News and Research

Study evaluates hepatocyte transplantation as an alternative to liver transplantation

Studies suggest potential therapeutic targets for food poisoning, TB and autoimmune diseases

CWRU receives $250,000 grant to advance interdisciplinary research and development in biomedicine

Findings could lead to new therapeutic strategies for obesity

Study shows antiviral drugs could offer protection against HIV, Ebola, herpes and hepatitis C

U.S. government resumes medical evacuations from Haiti; new food voucher distribution targeting women begins

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

ADT can worsen heart risk factors and may increase the risk of heart attack

PET for children: CHOP-Penn researchers study reduction in radiation dosage

Smoking cessation increases cardiac health later in life

SDI selected for third consecutive time as key monoclonal antibody provider

Mich., R.I. look for cuts in Medicaid costs; Mass. Governor suggests taxes, fees to cover rising costs

Scientists develop potential new treatment against ovarian cancer

Mouse model demonstrates cell-to-cell connections between implanted stem cells and diseased cells

Decision Resources: Benlysta to garner more than $500M in 2018

Nursing jobs no longer recession-proof

Some states mull requiring prescription for meth ingredients

Companies may hit new anti-discrimination law when asking workers about health issues

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

FDA and PATH collaborate to advance pneumococcal vaccine development for children

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring